Additional Information for Annual General Meeting of Shareholders

In relation to the Annual General Meeting of the Company to be convened on June 5, 2018, please find below additional information regarding the Agenda.

The AGM will discuss the following Agenda:

  1. Approval of the Annual Report of the Company for the year ended December 31, 2017, including the Activity Report of the Company, the Report of the Supervisory Role of the Board of Commissioners, approval and ratification of the Company's Audited Financial Statements for the year ended December 31, 2017 and to grant a release and discharge from their responsibilities to all members of the Board of Commissioners and Board of Directors for their management and supervision actions during the financial year ended December 31, 2017 (acquit et decharge);

  2. Approval on the appropriation of the Company's Net Profits for the financial year ended December 31, 2017;

  3. Changes in the composition of the Company's Board of Commissioners;

  4. Determination of salary and/or honorarium of the members of the Board of Commissioners and the Board of Directors and to authorize the Board of Commissioners to determine the salary and/or honorarium of the members of the Board of Directors;

  5. Appointment of Independent Public Accountant to audit the Company's Financial Statements for the year ended December 31, 2018 and authorize the Board of Directors to determine the honorarium of the Independent Public Accountant and other appointment's conditions.

Details on proposed AGM resolution:

  1. The Company proposes to approve the Annual Report of the Company for the year ended December 31, 2017, including the Activity Report of the Company, the Report of the Supervisory Role of the Board of Commissioners, approval and ratification of the Company's Audited Financial Statements for the year ended December 31, 2017 and to grant a release and discharge from their responsibilities to all members of the Board of Commissioners and Board of Directors for their management and supervision actions during the financial year ended December 31, 2017 (acquit et decharge);

  2. The Company proposes to distribute dividend in line with its dividend policy 45% - 55% of earnings, to allocate a portion of earnings as general reserve and to allocate the remaining as retained earnings;

  3. Following the demise of the Company's Independent Commissioner, Johannes Berchman Apik Ibrahim on March 1st, 2018, the Company proposes to confirm the existing composition of the Board of Commissioners.

Board of Commissioners:

President Commissioner : BERNADETTE RUTH IRAWATI SETIADY;

Commissioner : SANTOSO OEN;

Commissioner : FERDINAND ARYANTO;

Commissioner : RONNY HADIANA;

Independent Commissioner : FARID ANFASA MOELOEK;

Independent Commissioner : LUCKY SURJADI SLAMET;

4. The Company proposes to determine the amount of salary and/or honorarium of the Company's Board of Commissioners as a percentage of Company's net sales for year 2017 and granted authority to the Board of Commissioners of the Company by taking into account the input or recommendations of the Nomination and Remuneration Committee to determine the salary and/or honorarium of the members of the Board of Directors;

5. The Company proposes to appoint Public Accountant Firm Purwantono, Sungkoro & Surja to perform an audit on the Company's Financial Statements for the fiscal year ended December 31, 2018, by taking into account the input from Company's Board of Commissioners and the Audit Committee.

Attachments

  • Original document
  • Permalink

Disclaimer

PT Kalbe Farma Tbk published this content on 21 May 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 21 May 2018 10:29:03 UTC